Soluble CD23 in multiple myelomas and related diseases
| Autor: | Hiromitsu Matsuzaki, Tomoaki Matsumoto, Teruhisa Miike |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
lcsh:Immunologic diseases. Allergy
interleukin-1 α CD23 General Medicine Biology Chronic lymphatic leukemia multiple myelomas soluble CD23 Confidence interval immune system diseases hemic and lymphatic diseases Immunology Interleukin 1α Immunology and Allergy In patient Primary Macroglobulinemia lcsh:RC581-607 |
| Zdroj: | Allergology International, Vol 46, Iss 3, Pp 155-158 (1997) |
| ISSN: | 1323-8930 |
| DOI: | 10.2332/allergolint.46.155 |
| Popis: | The serum levels of soluble CD23 (sCD23) were examined in patients with multiple myelomas and related diseases and were compared with levels of sCD23 in healthy, age- and sex-matched controls. The mean levels (95% confidence intervals) of sCD23 in the sera of 40 patients with multiple myelomas, nine patients with myeloma-related diseases (seven primary macroglobulinemia and two chronic lymphatic leukemia) and 30 matched controls were 2.7 (1.9-3.8), 9.9 (5.1-19.2) and 1.5 (1.3-1.7) ng/mL, respectively, showing a significant increase in sCD23 in the circulation of patients with myelomas (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|